There is compelling evidence that suggests opioid addiction and overdose rates soared during the Covid-19 pandemic. Was this a direct result of Covid-19? Or was it a continuation of America’s opioid addiction epidemic?
The foremost commitment of any medical practitioner is to do no harm, and the vast majority of physicians hold to that. But what happens when the very drugs doctors prescribe are harmful?
The changes of the last several years must be tracked and understood if we are to reverse the terrible losses imposed on our country by those who make and traffic in fentanyl.
What is fentanyl? How did it become America’s worst drug problem? What can be done to prevent soaring fentanyl deaths?
Since the turn of the century, drug overdose fatalities have surged across America. While several different types of drugs have contributed to the crisis, opioids (especially fentanyl) have caused most of the deaths. How does one drug contribute to so much death across the country?
People who are addicted to drugs and alcohol experience multiple hardships due to their addiction. And in the last year, life has become even more challenging as increased isolation due to the Covid-19 pandemic has created an additional burden for struggling addicts.
The majority of doctors practice medicine with ethics, morality, and the intention to help. But when doctors do become immoral, people get hurt. This is the story of one such doctor.
It matters how businesses make their money. For Purdue Pharma, this multi-billion dollar corporation is being shut down due to the deaths caused by its frontline product, OxyContin. But is shutting the company down enough?
Overprescribing of opioid pain relievers is a serious issue. However, it's a relatively small group of physicians that are culpable in this. The majority of doctors are doing their best to treat their patients properly. It's just a few of them that are doling out opioid prescriptions in amounts that far exceed prescribing guidelines.
For some time, the U.S. drug problem has seemed entirely unique. But now, similar problems are beginning to develop in Europe. How will European countries tackle their drug problems?